Apiam Animal Health Limited (ASX:AHX)
Australia · Delayed Price · Currency is AUD 0.8750
+0.0050 (0.57%)
Inactive · Last trade price on Feb 6, 2026
Apiam Animal Health Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 206.92 | 204.66 | 191.76 | 157.06 | 126.18 | |
Revenue Growth (YoY) | 1.11% | 6.73% | 22.09% | 24.47% | 6.63% |
Cost of Revenue | 160.04 | 158.16 | 152.41 | 122.72 | 100.87 |
Gross Profit | 46.88 | 46.5 | 39.35 | 34.34 | 25.32 |
Selling, General & Admin | - | - | - | - | 2.14 |
Other Operating Expenses | 21.69 | 22.16 | 22.24 | 18.2 | 8.54 |
Operating Expenses | 34.44 | 34.14 | 32.47 | 26.55 | 17.1 |
Operating Income | 12.44 | 12.36 | 6.88 | 7.78 | 8.21 |
Interest Expense | -5.65 | -5.52 | -3.77 | -1.57 | -1.18 |
Earnings From Equity Investments | -0.01 | 0.05 | 0.05 | 0.09 | 0.08 |
Other Non Operating Income (Expenses) | 0.62 | - | - | - | - |
EBT Excluding Unusual Items | 7.4 | 6.89 | 3.16 | 6.3 | 7.12 |
Merger & Restructuring Charges | - | - | -0.32 | - | -0.17 |
Impairment of Goodwill | -3.45 | - | - | - | - |
Gain (Loss) on Sale of Assets | 0.58 | 0.17 | 0.32 | 0.17 | 0.02 |
Asset Writedown | -1.68 | - | - | - | - |
Pretax Income | 2.86 | 7.06 | 3.17 | 6.47 | 6.97 |
Income Tax Expense | 2 | 2.15 | 1 | 1.93 | 2.02 |
Earnings From Continuing Operations | 0.86 | 4.91 | 2.17 | 4.54 | 4.95 |
Minority Interest in Earnings | -0.03 | 0.02 | 0.11 | 0.1 | 0.09 |
Net Income | 0.83 | 4.93 | 2.28 | 4.64 | 5.04 |
Net Income to Common | 0.83 | 4.93 | 2.28 | 4.64 | 5.04 |
Net Income Growth | -83.13% | 116.56% | -50.92% | -7.88% | 22.98% |
Shares Outstanding (Basic) | 181 | 179 | 175 | 136 | 121 |
Shares Outstanding (Diluted) | 187 | 182 | 178 | 138 | 122 |
Shares Change (YoY) | 2.66% | 2.38% | 28.68% | 13.16% | 6.75% |
EPS (Basic) | 0.00 | 0.03 | 0.01 | 0.03 | 0.04 |
EPS (Diluted) | 0.00 | 0.03 | 0.01 | 0.03 | 0.04 |
EPS Growth | -83.77% | 111.73% | -61.91% | -18.64% | 15.36% |
Free Cash Flow | 11.75 | 14.1 | 9.55 | 10.72 | 8.95 |
Free Cash Flow Per Share | 0.06 | 0.08 | 0.05 | 0.08 | 0.07 |
Dividend Per Share | 0.020 | 0.020 | - | 0.016 | 0.024 |
Dividend Growth | - | - | - | -33.33% | 20.00% |
Gross Margin | 22.66% | 22.72% | 20.52% | 21.86% | 20.06% |
Operating Margin | 6.01% | 6.04% | 3.59% | 4.96% | 6.51% |
Profit Margin | 0.40% | 2.41% | 1.19% | 2.95% | 3.99% |
Free Cash Flow Margin | 5.68% | 6.89% | 4.98% | 6.82% | 7.09% |
EBITDA | 19.4 | 19.34 | 12.98 | 12.82 | 12.11 |
EBITDA Margin | 9.37% | 9.45% | 6.77% | 8.16% | 9.60% |
D&A For EBITDA | 6.96 | 6.98 | 6.1 | 5.04 | 3.9 |
EBIT | 12.44 | 12.36 | 6.88 | 7.78 | 8.21 |
EBIT Margin | 6.01% | 6.04% | 3.59% | 4.96% | 6.51% |
Effective Tax Rate | 69.79% | 30.50% | 31.43% | 29.84% | 28.99% |